文献速递乳房整形与再造显微修复重建

单期背阔肌-假体乳房重建安全可靠:单术者207皮瓣系列

Single-Stage Latissimus-Implant Breast Reconstruction Is Safe and Reliable: A Single Surgeon Series of 207 Flaps.
PubMed 文献 · Ann Plast Surg · 2025-01-01

初次与挽救重建的总体并发症率(35.8% vs 43.3%,P=0.426)和修整率(39.1% vs 40.0%,P=0.926)无显著差异。单期背阔肌+假体是最常用方式(189皮瓣,90.4%),作者认为单期背阔肌/假体重建对初次和挽救重建均安全可靠。

要点

  • 单术者207皮瓣中,189皮瓣(90.4%)采用单期背阔肌+假体,14皮瓣(6.7%)单期背阔肌 alone。
  • 最常见并发症为包膜挛缩(29%),去除包膜挛缩后分期组间并发症率无差异。
  • 初次与挽救重建的总体并发症率(35.8% vs 43.3%,P=0.426)和修整率(39.1% vs 40.0%,P=0.926)无显著差异。

核心结论

  • 单期背阔肌/假体乳房重建对初次和挽救重建仍是安全可靠的手术选择。
  • 包膜挛缩发生率较高,应促使采用降低其发生率的技术。

研究设计与样本

  • 单术者系列,纳入2008至2021年接受背阔肌皮瓣乳房重建的患者,共156例患者、207皮瓣。
  • 回顾病历收集人口学、适应证、计划分期数量与类型及结局,比较适应证组和分期组间的急慢性并发症与修整。

主要发现

  • 分期构成:单期背阔肌 alone 14皮瓣(6.7%),单期背阔肌+假体189皮瓣(90.4%),二期背阔肌+假体1皮瓣(0.5%),二期背阔肌+组织扩张器后假体5皮瓣(2.4%)。
  • 平均随访44.9个月(范围1-164个月),最常见并发症为包膜挛缩(29%)。
  • 初次与挽救重建的总体并发症率(35.8% vs 43.3%,P=0.426)及修整率(39.1% vs 40.0%,P=0.926)无显著差异。
  • 分期组间并发症率有显著差异(P=0.021)而修整率无显著差异(P=0.133):单期背阔肌 alone 7.1%、14.3%;单期背阔肌+假体40.2%、41.8%;二期背阔肌+假体0.0%、0.0%;二期背阔肌+扩张器后假体0.0%、20.0%。

关键数值与推荐

  • 单期背阔肌 alone 14皮瓣(6.7%),单期背阔肌+假体189皮瓣(90.4%),二期背阔肌+假体1皮瓣(0.5%),二期背阔肌+组织扩张器后假体5皮瓣(2.4%)。
  • 初次重建并发症率35.8% vs 挽救重建43.3%(P=0.426),修整率39.1% vs 40.0%(P=0.926)。
  • 分期组并发症率(P=0.021)与修整率(P=0.133)比较:单期背阔肌 alone 7.1%、14.3%;单期背阔肌+假体40.2%、41.8%;二期背阔肌+假体0.0%、0.0%;二期背阔肌+扩张器后假体0.0%、20.0%。
  • 包膜挛缩发生率29%。

临床怎么用

  • 单期背阔肌/假体乳房重建可作为初次和挽救乳房重建的安全可靠选择。
  • 针对包膜挛缩高发(29%),应部署降低其发生率的技术。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The latissimus dorsi flap (LDF) is a historical workhorse and contemporary salvage mainstay for breast reconstruction. There is still debate regarding timing and staging, with some authors advocating for staged reconstruction using tissue expanders. We present a single-surgeon experience with LDF breast reconstruction and compare the results of single-stage reconstruction versus staged approaches. METHODS: Patients undergoing LDF breast reconstruction from 2008 to 2021 with a single surgeon (R.S.) were included. Charts were reviewed for demographics, indications, number and type of planned stages, and outcomes. Acute and chronic complications and revisions were compared between indication and staging groups. RESULTS: A total of 156 patients underwent LDF breast reconstruction, of which 111 flaps (53.1%) were bilateral. One hundred seventy-nine (85.6%) flaps were for primary reconstruction, and 30 (14.4%) flaps were for salvage of a previous breast reconstruction. Fourteen (6.7%) flaps were 1-stage LDF alone, 189 (90.4%) were 1-stage LDF with implant, 1 (0.5%) was 2-stage LDF with implant, and 5 (2.4%) were 2-stage LDF with tissue expander then implant. The mean follow-up was 44.9 months (range, 1-164 months). The most common complication was capsular contracture (29%). Overall complication rates were similar between primary and salvage reconstruction (35.8% vs 43.3%, P = 0.426), as was needed for revision (39.1% vs 40.0%, P = 0.926). There was a significant difference in complication rate (P = 0.021) but not revision rate (P = 0.133) between staging groups: 1-stage LDF alone, 7.1%, 14.3%; 1-stage LDF with implant, 40.2%, 41.8%; 2-stage LDF with implant, 0.0%, 0.0%; and 2-stage LDF with expander then implant, 0.0%, 20.0%. After removing capsular contracture, there was no difference in complication rates. CONCLUSIONS: Single-staged LDF/implant reconstruction remains a safe and reliable surgical option for both primary and salvage breast reconstruction. High rates of capsular contracture should prompt the deployment of techniques to reduce its incidence.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Aref Y, Samaha Y, Almadani H, et al. Single-Stage Latissimus-Implant Breast Reconstruction Is Safe and Reliable: A Single Surgeon Series of 207 Flaps. Ann Plast Surg. 2025. PMID: 40310010. doi:10.1097/SAP.0000000000004283

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。